One year follow-up of patients with bullous pemphigoid;Profil évolutif des patients atteints de pemphigoïde bulleuse au cours de la premire année de traitement

Annales de Dermatologie et de Venereologie

Volumn 136, Issue 5, 2009, Pages 407-411

  Bedane C ^a   Doffoel Hantz, V ^a   Sparsa, A ^a   Marin, B ^a   Durox, H ^a   Bonnetblanc, J M ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Bullous pemphigoid; Topical corticosteroids

Indexed keywords

CORTICOSTEROID; DAPSONE; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGED; ARTICLE; BULLOUS PEMPHIGOID; DISEASE ASSOCIATION; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FOLLOW UP; FRANCE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PROGNOSIS; RELAPSE; REMISSION; RISK ASSESSMENT; SYMPTOMATOLOGY; TREATMENT FAILURE; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PEMPHIGOID, BULLOUS; PROBABILITY; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVORS;

EID: 67349167135     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2009.01.009     Document Type: Article

References (20)

1. Bullous diseases French study group P. Bernard, L. Vaillant, B. Labeille, C. Bedane, B. Arbeille, and J.P. Denoeux Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions Arch Dermatol 131 1995 48 52
2. S. Baricault, A. Sparsa, P. Courville, P. Bravard, C. Bédane, and P. Joly Incidence de la pemphigoïde bulleuse Ann Dermatol Venereol 133 2006 4S1
3. P. Joly Incidence of bullous pemphigoid and pemphigus vulgaris BMJ 337 2008 a209
4. N. Cordel, O. Chosidow, M.F. Hellot, E. Delaporte, C. Lok, and L. Vaillant Neurological disorders in patients with bullous pemphigoid Dermatology 215 2007 187 191 (Pubitemid 47378983)
5. S. Beissert, T. Werfel, U. Frieling, M. Bohm, M. Sticherling, and R. Stadler A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid Arch Dermatol 143 2007 1536 1542 (Pubitemid 350277770)
6. P. Bernard, V. Enginger, J. Venot, C. Bedane, and J.M. Bonnetblanc Pronostic vital de la pemphigoïde bulleuse : analyse d'une cohorte de 78 malades Ann Dermatol Venereol 122 1995 751 757 (Pubitemid 26072684)
7. J.C. Roujeau, C. Lok, S. Bastuji-Garin, S. Mhalla, V. Enginger, and P. Bernard High risk of death in elderly patients with extensive bullous pemphigoid Arch Dermatol 134 1998 465 469 (Pubitemid 28207630)
8. S.R. Parker, S. Dyson, S. Brisman, M. Pennie, R.A. Swerlick, and R. Khan Mortality of bullous pemphigoid: an evaluation of 223 patients and comparison with the mortality in the general population in the United States J Am Acad Dermatol 59 2008 582 588
9. P. Bernard, C. Bedane, and J.M. Bonnetblanc Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients Br J Dermatol 136 1997 694 698 (Pubitemid 27278076)
10. P. Bernard, J. Venot, F. Constant, and J.M. Bonnetblanc Blood eosinophilia as a severity marker for bullous pemphigoid J Am Acad Dermatol 16 1987 879 881
11. P. Joly, J. Benichou, C. Lok, M.F. Hellot, P. Saiag, and E. Tancrede-Bohin Prediction of survival for patients with bullous pemphigoid: a prospective study Arch Dermatol 141 2005 691 698 (Pubitemid 41001068)
12. P. Joly, J.C. Roujeau, J. Benichou, C. Picard, B. Dreno, and E. Delaporte A comparison of oral and topical corticosteroids in patients with bullous pemphigoid N Engl J Med 346 2002 321 327 (Pubitemid 34438839)
13. P. Joly, J.C. Roujeau, E. Delaporte, C. Bedane, P. Bernard, and E. Tancrede-Bohin Comparaison de deux stratégies thérapeutiques de corticothérapie locale dans le traitement de la pemphigoïde bulleuse Ann Dermatol Venereol 133 2006 4S3
14. French bullous study group L. Vaillant, P. Bernard, P. Joly, C. Prost, B. Labeille, and C. Bedane Evaluation of clinical criteria for diagnosis of bullous pemphigoid Arch Dermatol 134 1998 1075 1080
15. V.S. Gudi, M.I. White, N. Cruickshank, R. Herriot, S.L. Edwards, and F. Nimmo Annual incidence and mortality of bullous pemphigoid in the Grampian region of North-east Scotland Br J Dermatol 153 2005 424 427 (Pubitemid 41228445)
16. S.M. Langan, L. Smeeth, R. Hubbard, K.M. Fleming, C.J. Smith, and J. West Bullous pemphigoid and pemphigus vulgaris-incidence and mortality in the UK: population-based cohort study BMJ 337 2008 a180
17. Joly P, Roujeau JC, Benichou J, Delaporte E, D'Incan M, Dreno B, et al. A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. J Invest Dermatol, sous presse.
18. M. Pfutze, A. Niedermeier, M. Hertl, and R. Eming Introducing a novel Autoimmune bullous skin disorder intensity score (ABSIS) in pemphigus Eur J Dermatol 17 2007 4 11 (Pubitemid 46383213)
19. Z. Reguiaï, E. Tancrede-Bohin, N. Cordel, P. Plantin, C. Pauwels, and L. Vaillant La positivité de l'immunofluorescence directe l'arrêt de la corticothérapie est le principal facteur prédictif de rechute de pemphigoïde bulleuse Ann Dermatol Venereol 133 2006 4S2
20. Y. Iwata, K. Komura, M. Kodera, T. Usuda, Y. Yokoyama, and T. Hara Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid Arch Dermatol 144 2008 41 48